Survey Reveals Biotech Professionals' Attitude Toward New Business Models - Applied Clinical Trials

ADVERTISEMENT

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
See our 2009 Buyers Guide Digital Edition.
Find Pharma Search Engine
Survey Reveals Biotech Professionals' Attitude Toward New Business Models
Sep 30, 2009

As the biotech industry continues to face changes in funding, companies are forced to reevaluate their business strategies. In a recent biotech industry survey, Industry Standard Research surveyed 112 biotech professionals on a range of issues from their observations in valuation changes to their ideal clinical development plans for the future of their company.

The following table shows the results of respondents' answers to the question: Given that some of the more traditional avenues to drug development could be facing problems, from the list below please indicate any change in your company’s stance or relative interest in using each drug development model/partner. As you will see from the following responses, choices varied greatly.

Source: Industry Standard Research, 2009.

You can view the full report here.

For more information on biotech, please see:


More Data Points:

Patient Recruitment: Time vs Money
Diabetes Drug Development
Comparing Subject Recruitment Advertising Strategies
Digital Signatures On the Rise
CRAs Feel Workload Increase

ADVERTISEMENT

ADVERTISEMENT

Enrollment Planning for Critical Path Studies
Conducting Trials in Croatia
To Market Faster In Silico Style
Is an Investigative Site Shake-Out Imminent?
EDC Acceptance in Japan
FindPharma
Featured Jobs

More Jobs

Survey
Would you ever consider working as a freelance clinical research professional?
Yes, I'd love to
Yes, but would never do it
No, but may have to
Absolutely not, no stability
Yes, I'd love to
75%
Yes, but would never do it
8%
No, but may have to
17%
Absolutely not, no stability
0%
View Results
9/30/2009
Click here